Filter
633
Text search:
TB/HIV
Featured
55
191
Language
Document type
428
65
48
31
21
19
10
8
3
Countries / Regions
38
21
20
19
19
18
17
16
14
13
12
12
12
11
11
10
9
9
9
9
9
8
8
8
8
7
7
6
6
6
5
5
4
4
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
308
41
15
12
8
5
2
Toolboxes
275
81
23
11
10
9
7
7
6
5
4
2
2
2
2
2
1
Towards a world free of tuberculosis
Rappart sur les populations clés.
The 7th edition of the Orange Guide provides practical guidance to health workers on the front line of TB control. It includes sections on HIV, MDR-TB and a review of the recommended treatment regimens
The overall objective of this implementation plan is to define the strategy for implementation of the Xpert MTB/RIF test for rapid detection of TB and rifampicin (RIF) resistance in Tanzania, within the context of the National Tuberculosis and Leprosy Programme (NTLP) strategic plan and other nation
...
Information note.
This information note provides a strategic overview of key implementation considerations for diagnostic integration using these devices, and is primarily intended for use by national laboratory services and TB, ...
This information note provides a strategic overview of key implementation considerations for diagnostic integration using these devices, and is primarily intended for use by national laboratory services and TB, ...
The modules (1-12) are based on materials originally developed by FIND, KNCV and Cepheid, and are in PowerPoint format for country customization. Depending on the audience, modules may be selected and adapted according to need (e.g. basic users, supervisors, clinicians). Topics covered include: Over
...
HIV/TB workplace policy and Implementation Strategy
Stop TB Communicable Diseases
Guidance on TB and TB/HIV prevention, diagnosis, treatment and care in the workplace
Regional Eastern European and Central Asian project (TB-REP) Copenhagen, Denmark, 26–28 April 2016
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
